Enhancement of antitumor immunity by CTLA-4 blockade

Science

Volumn 271, Issue 5256, 1996, Pages 1734-1736

  Leach, Dana R ^a   Krummel, Matthew F ^a   Allison, James P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;

ANIMAL EXPERIMENT; ARTICLE; IMMUNOGENICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TUMOR IMMUNITY; TUMOR REJECTION;

ANIMALIA;

EID: 0029947568     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.271.5256.1734     Document Type: Article

References (34)

1. D. L. Mueller, M. K. Jenkins, R. H. Schwartz, Ann. Rev. Immunol 7, 445 (1989).
2. P S Linsley and J A Ledbetter, ibid 11, 191 (1993)
3. C. H June. J. A. Bluestone, L M Nadler, C B Thompson, Immunol. Today 15, 321 (1994)
4. J P. Allison. Curr. Opin. Immunol 6, 414 (1994).
5. L Chen, S. Ashe, W A. Brady, I. Hellstrom, K. E. Hellstrom et al., Cell 71. 1093 (1992).
6. S E Townsend and J. P. Allison, Science 259, 368 (1993).
7. S Baskar et al , Proc. Natl. Acad Sci U.S.A 90, 5667 (1993).
8. J P Allison, A A Hurwitz, D R. Leach, Curr Opin Immunol. 7. 682 (1995).
9. M K. Jenkins, Immunity 1, 443 (1994).
10. J A. Bluestone ibid. 2, 555 (1995).
11. P. S. Linsley, J. Exp. Med. 182. 289 (1995).
12. J. P Allison and M F Krummel, Science 270, 932 (1995)
13. J F. Brunet et al., Nature 328, 267 (1987)
14. K Harper et al., J Immunol 147, 1037 (1991)
15. P S. Linsley et al., J. Exp. Med. 174, 561 (1991)
16. P S Linsley et al., Immunity 1, 793 (1994).
17. T. L Walunas et al , ibid., p 405
18. M. F Krummel and J P. Allison, J Exp Med 182, 459 (1995) Antibodies used in these studies were protein G-purifled from hybridoma supernatants and quantified by ultraviolet spectrophotometry
19. E R. Kearney et al , J. Immunol 155, 1033 (1995)
20. M F Krummel, T. J. Sullivan, J. P. Allison, Int. Immunol , in press.
21. J. G. Gribben et al., Proc. Natl Acad Sci. U S A 92. 811 (1995).
22. P. Waterhouse et al., Science 270, 985 (1995)
23. 7 cells per milliter. Expression of B7-1 molecules on transfected cells was verified by flow cytometry before injection V51 BLim10 and wild-type 51BLim10 tumor cells do not express detectable amounts of B7-1, B7-2, or CTLA-4 as determined by flow cytometric analyses.
24. J A. Gross, E. Callas, J. P. Allison, J. Immunol 149. 380 (1992)
25. D. R. Leach, M F. Krummel, J. P. Allison, data not shown.
26. S. Baskar, L Glimcher, N Nabavi, R. T. Jones, S Ostrand-Rosenberg, J Exp. Med. 181, 619 (1995)
27. A Y C Huang et al., Science 264, 961 (1994).
28. S. Ostrand-Rosenberg, A Thakur, V. Clements, J Immunol 144, 4068 (1990).
29. D. R. Leach and G N Callahan, ibid. 154, 738 (1995).
30. G. Dranoff et al., Proc. Natl. Acad. Sci. U S A 90 3539 (1993).
31. H. I. Levitsky, A Lazenby, R. J. Hayashi, D. M. Pardoll, J. Exp Med 179. 1215 (1994).
32. V. Flamand et al , Eur J Immunol 24, 605 (1994)
33. S Grabbe, S. Beissert, T Schwarz. R. D Granstein, Immunol. Today 16, 117 (1995).
34. We thank S Ostrand-Rosenberg and R Warren for providing tumor lines. Supported by NIH grants CA57986, CA09179, and CA40041.